João Madaleno

João Madaleno

Auto-generated profile, based on publicly available information

João Madaleno

Universidade de Coimbra

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2015 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
ASAdélia Simão
Adélia Simão
JMJoão Madaleno
João Madaleno
NSNuno Silva
Nuno Silva
FRFernando Rodrigues
Fernando Rodrigues
PCPaula Caseiro
Paula Caseiro
ACArmando Carvalho
Armando Carvalho
Implementation of surveillance programs for at-risk populations and identification of biomarkers for early hepatocellular carcinoma (HCC) detection are a major public health goal. Recently, osteopontin (OPN) has attracted attention as a promising biomarker, with some potential advantages compared to alpha-fetoprotein (AFP), but its role in the context of alcoholic cirrhosis has never been assessed. The aims of this study are to assess the utility of plasma OPN in the diagnosis of HCC in alcoholic cirrhotic patients and to investigate whether increased values are due to the tumor or underlying liver disease severity. A total of 90 consecutively alcoholic cirrhosis patients, observed between Jun 2013 and May 2014 at a Liver Disease Unit, were included and divided into two groups: 45 without (group I) and 45 with HCC (group II). Plasma levels of OPN (ELISA, Immuno-Biological Laboratories, Gunma, Japan) and AFP (IMMULITE® 2000 AFP, Siemens Healthcare Diagnostics, Tarrytown, New York) were assessed. The diagnostic accuracy of each marker was evaluated using Receiver-Operating Characteristic (ROC) curve analysis (AUC) and its 95 % Confidence Interval (CI). Plasma OPN levels in group I patients (1176.28 +/–744.59 ng/mL) weren’t significantly different from those of group II (1210.75 +/–800.60 ng/mL) (p = 0.826). OPN levels significantly increased with advancing BCLC tumor stage and with advancing Child-Pugh class, in both groups. Comparing the two groups, AUC for OPN and AFP were 0.51 (95 % CI: 0.39–0.63) and 0.79 (95 % CI: 0.70–0.89), respectively. Based on the ROC analysis, there were no satisfactory cut-off values for OPN that would distinguish patients with from those without tumour. Despite having a correlation with BCLC stage, the same was observed with progressive deterioration of underlying liver function in terms of Child-Pugh class and MELD score, and isn’t a useful diagnostic biomarker for HCC in alcoholic cirrhotic patients, particularly in the early stages. AFP confirms the performance evidenced in other studies, being superior to OPN. Searching more specific biomarkers for early diagnosis of HCC in alcoholic cirrhosis is still warranted.

1 May 2015 in Transplantation Proceedings
Verified
Journal Article
Closed access
JMJ. Madaleno
J. Madaleno
RARui Alves
Rui Alves
NSN. Silva
N. Silva
SCS. Calretas
S. Calretas
LTL. Tomé
L. Tomé
ACArmando Carvalho
Armando Carvalho

25 January 2023 in Brazilian Journal of Transplantation
Verified
Journal Article
Open access
DDDaniel Francisco Medina Dias
Daniel Francisco Medina Dias
DDDulce Diogo
Dulce Diogo
JMJoão Madaleno
João Madaleno
José Guilherme TralhãoJosé Guilherme Tralhão
José Guilherme Tralhão
Introdução: A escassez de órgãos para transplantação hepática impõe uma seleção criteriosa dos doentes com falência hepática aguda. Vários modelos de prognóstico foram desenvolvidos para selecionar os doentes para transplantação. Essa síndrome pode evoluir rapidamente para falência multiorgânica. Assim, vários sistemas de suporte hepático extracorporal foram aperfeiçoados, com o objetivo de fazer a ponte para transplantação ou assegurar a recuperação do doente. Objetivos: Rever os principais critérios de seleção para transplantação hepática nos doentes com falência hepática aguda, incidindo sobretudo sobre os novos marcadores. Identificar os critérios de mau prognóstico associados a futilidade terapêutica. Rever os principais sistemas de suporte hepático extracorporal, analisando o seu impacto na sobrevida dos doentes com falência hepática aguda. Métodos: A pesquisa foi realizada na MEDLINE e Pubmed entre 16 de outubro de 2021 e 5 de dezembro de 2021. Os critérios de inclusão foram: doentes adultos; doentes com lesão hepática aguda ou falência hepática aguda; estudos observacionais; estudos clínicos; séries de casos clínicos; estudos caso-controle; revisões sistemáticas; meta-análises. Discussão: Os critérios de King’s College têm sido amplamente utilizados. No entanto, apesar de boa especificidade, apresentam sensibilidade reduzida. Vários marcadores foram utilizados para melhorar a sua acuidade prognóstica, mas sem resultados claros até ao momento. Vários estudos apontaram a idade do doente, a incompatibilidade ABO e má qualidade do enxerto como potenciais fatores para futilidade terapêutica. Os sistemas de suporte hepático extracorporal têm influência positiva nos parâmetros clínicos e laboratoriais; no entanto, não demonstram claro aumento da sobrevida desses doentes. Conclusão: Este estudo permite concluir que a falência hepática aguda é uma síndrome heterogénea, o que prejudica a qualidade dos estudos efetuados para avaliar o impacto dos critérios de prognóstico na sobrevida dos doentes com falência hepática aguda, mas também tem limitado os estudos efetuados para avaliar o impacto dos sistemas de suporte hepático extracorporal na sobrevida.

5 February 2014 in BMC Neurology
Verified
Journal Article
Open access
PDF file
JSJoão Sargento-Freitas
João Sargento-Freitas
RFRicardo Felix-Morais
Ricardo Felix-Morais
JRJoana Ribeiro
Joana Ribeiro
AGAna Gouveia
Ana Gouveia
CNCésar Nunes
César Nunes
LCLuís Cunha
Luís Cunha
Subcortical hypodensities of presumed vascular etiology (SHPVO) are a clinical, radiological and neuropathological syndrome with a still largely unexplained pathophysiology. Parallel to the clinical heterogeneity, there is also recognised cerebral topographical diversity with undetermined etiological implications. Our aim is to assess clinical and neurosonological predictors of SHPVO according to their location. Cross sectional analysis of consecutive patients that underwent neurosonologic evaluation and head CT within one month, during a one year period. We excluded patients with absent temporal sonographic window, any pathology with a possible confounding effect on cerebral arterial pulsatility, atrial fibrillation and other etiologies of white matter diseases. The mean pulsatility index (PI) of both middle cerebral arteries was measured in the middle third of the M1 segment; intima media thickness was evaluated in the far wall of both common carotid arteries. SHPVO were rated by analysis of head CT in deep white matter (DWMH), periventricular white matter (PVWMH) and basal ganglia (BGH). We conducted a multivariate ordinal logistic regression model including all clinical, demographic and ultrasonographic characteristics to determine independent associations with SHPVO. We included 439 patients, mean age 63.47 (SD: 14.94) years, 294 (67.0%) male. The independent predictors of SHPVO were age (OR = 1.067, 95% CI: 1.047-1.088, p < 0.001 for DWMH; OR = 1.068, 95% CI: 1.049-1.088, p < 0.001 for PVWMH; OR = 1.05, 95% CI: 1.03-1.071, p < 0.001 for BGH), hypertension (OR = 1.909, 95% CI: 1.222-2.981, p = 0.004 for DWMH; OR = 1.907, 95% CI: 1.238-2.938, p = 0.003 for PVWMH; OR = 1.775, 95% CI: 1.109-2.843, p = 0.017 for BGH) and PI (OR = 17.994, 95% CI: 6.875-47.1, p < 0.001 for DWMH; OR = 5.739, 95%CI: 2.288-14.397, p < 0.001 for PVWMH; OR = 11.844, 95% CI: 4.486-31.268, p < 0.001 for BGH) for all locations of SHPVO. Age, hypertension and intracranial pulsatility are the main independent predictors of SHPVO across different topographic involvement and irrespective of extracranial atherosclerotic involvement.

28 March 2025 in JHEP Reports
Verified
Journal Article
Open access
KWKarsten Vanden Wyngaert
Karsten Vanden Wyngaert
JSJanne Suykens
Janne Suykens
DKDeirdre Kelly
Deirdre Kelly
IGIsabel Gonçalves
Isabel Gonçalves
ETEna Lindhart Thomsen
Ena Lindhart Thomsen
RBRuth De Bruyne
Ruth De Bruyne
The transfer journey from pediatric to adult care services of young people with rare liver diseases poses significant challenges and is an underexplored research area. This study examined the critical aspects of, and opportunities for, transfer journey management for these young people in Europe. In total, 72 individuals, representing 13 countries, participated in an omnistakeholder workshop on 17–18 March 2023. A standardized workshop methodology was used to discuss critical aspects and actions over nine focus sessions. The themes of these sessions were identified by engaging with healthcare providers, young people, and parents. Results (i.e. aspects receiving >25% of the votes) were ranked based on importance and validated by the European Reference Network of Hepatological Diseases (ERN RARE-LIVER) youth panel. Our findings revealed that the critical aspects of transfer journey management predominantly revolved around the transfer itself. Most of the critical aspects and actions were related to improving communication (e.g. allocating sufficient time, 81% of votes; giving consistent information, 43%; and discussing communication preferences, 100%), relational continuity (e.g. appointing a transition person to liaison between stakeholders, 79%), and management continuity (e.g. using a transfer document, 60%). Our results also underscored the importance of peer mentorship programs (100%), informing young people about the transfer process (85%), and implementing joint consultations (93%). Current literature and guidelines on ‘transition’ might not fully address real-world challenges in rare liver diseases, particularly those concerning maintaining continuity of care during the actual transfer process. Future research should examine the effectiveness of strategies aimed at enhancing communication and continuity of care throughout the transfer journey, focusing on stakeholder experience. This international omnistakeholder workshop explored challenges and opportunities in managing transfer journeys for young people with rare liver diseases. By emphasizing practical implications (leading to actions), it provides a benchmark for improving transfer journeys worldwide, applicable to not only rare liver diseases, but possibly also common liver or other rare diseases. Our findings underscore the fundamental importance of the transfer itself in maintaining continuity of care. The critical aspects identified center around informative, relational, and management continuity of care and have been transformed into minimal criteria.

8 March 2016 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
JMJoão Madaleno
João Madaleno
AFAntónio Fernandes
António Fernandes
JCJoana Cochicho
Joana Cochicho
NSNuno Silva
Nuno Silva
ACArmando Carvalho
Armando Carvalho